Target intelligence / Profile preview

Tetratricopeptide repeat domain 28 (TTC28)

Target
TTC28
Molecular classification
Other, Structural protein, Cell division regulatory protein
01

Overview

Tetratricopeptide repeat domain 28 (TTC28) is a large (271 kDa) scaffold protein containing multiple tetratricopeptide repeat (TPR) domains that facilitate protein-protein interactions, particularly during cell division[1][2][8]. TTC28 is essential for the regulation of mitosis and cytokinesis by organizing spindle midzone microtubules and midbody formation, processes crucial for proper cell division[2][7][8]. It interacts with HSPA8 and LAMP2A, serving as a substrate for chaperone-mediated autophagy, and is rapidly degraded via this pathway[1][3]. Loss or mutation of TTC28 leads to chromosomal instability, which is a hallmark of cancer and may sensitize cancer cells to drugs that inhibit mitosis and cytokinesis[1][3]. TTC28 is not classified as a conventional therapeutic target like a receptor or enzyme, but is increasingly recognized for its role in maintaining genome integrity and as a potential biomarker or research target in oncology[1][5][3].

Other names
Tetratricopeptide repeat domain 28TTC28TPRBKKIAA1043TPR repeat protein 28TPR repeat-containing big gene cloned at KeioTPR-containing big gene cloned at Keio
02

Mechanism of action

Not applicable

03

Biological functions

Regulation of chromosomal stabilityRegulation of mitotic cell cycle (mitosis and cytokinesis)Scaffold/protein-protein interaction via TPR domains—binds HSPA8, LAMP2ACondensation of spindle midzone microtubules, midbody formation during cell division
04

Disease associations

CancerPotential role in other diseases involving cell division or chromosomal integrity (not well described)
05

Biomarkers

γH2AX, comet assay (for DNA damage/genomic instability resulting from TTC28 loss; not specific to TTC28 but used in relevant studies)TTC28 expression/mutation status (potentially prognostic or predictive in cancer, under early investigation)

Beyond the preview

Go deeper on Tetratricopeptide repeat domain 28 (TTC28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetratricopeptide repeat domain 28 (TTC28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call